Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

zalcitabine(6 products available)
indiabuy
Supplier Type
Supplier Region
Purity
Package

Zalcitabine

  • CAS:7481-89-2
  • MF:C9H13N3O3
  • MW:211.22
  • EINECS:620-762-3
Melting point::
217-218 °C(lit.)
Boiling point::
350.9°C (rough estimate)
alpha :
D25 +81° (c = 0.635 in water)
Density :
1.2605 (rough estimate)
refractive index :
78 ° (C=0.5, H2O)
storage temp. :
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility :
DMSO (Slightly, Heated), Methanol (Slightly), Water (Slightly, Sonicated)
form :
powder
pka:
14.44±0.10(Predicted)
color :
colorless
Water Solubility :
5-10 g/100 mL at 19 ºC
Merck :
14,10109
BRN :
654956
Stability::
Stable. Combustible. Incompatible with strong oxidizing agents.
InChIKey:
WREGKURFCTUGRC-POYBYMJQSA-N
Symbol(GHS) 

GHS08
Signal word 
Warning
Hazard statements 
H351
Precautionary statements 
P281
More Chemical Properties
1/2

Dideoxycytidine    7481-89-2

Manufacturer
Note:Purity: 98% | Package: 1 kg,5 kg, 10 kg,25kg and 1 MT
1Y Telangana
Phone: +919177075735
Whatsapp: +91 9177075735
Product catalog: 694
Inquiry

Zalcitabine   7481-89-2

Trader
Maharashtra
Phone: 91-9075014125
Tel: 91-20-24454597
Whatsapp: 91-9075014125
Web:
Product catalog: 3427
Inquiry

Zalcitabine   7481-89-2

Trader
Maharashtra
Tel: 91-22-23455220
Product catalog: 577
Inquiry

Zalcitabine    7481-89-2

Pack Size
Purity
Availability
Price
100mg
≥98% (HPLC)
In stock Inquiry
49634.5
Update time:2024-08-21
New Delhi
Phone: 1-800-309-5000
Web:
Product catalog: 157135
Inquiry
New Delhi
Phone: 1-800-209-7001
Web:
Product catalog: 14305
Inquiry

2,3-Dideoxycytidine (ddC) extrapure    7481-89-2

Pack Size
Purity
Availability
Price
25Mg
98%
In stock PackSize:25Mg,TypicalLeadTime:Availability:1week
3150
Update time:2024-08-21
New Delhi
Phone: 91-22-42685800
Web:
Product catalog: 2945
Inquiry